ADVISORY BOARD

Review

Reviewing the guidelines for the Saudi Network for Clinical Trials.

Contribute

Contributing to the development and review of the policies to support the Saudi Network for Clinical Trials

Advise

Advising on best practices of similar international institutions

Participate

Participating and promoting the conduct of high standards clinical trials in the Kingdom of Saudi Arabia.

Help

Helping promote the reputation of the Saudi Network for Clinical Trials locally, regionally, and internationally.

OUR BOARD MEMBERS

Dr. Ahmed Alaskar
Dr. Ahmed AlaskarKAIMRC/MNG-HA (Chairman)
Dr. Abdelali Haoudi
Dr. Abdelali HaoudiKAIMRC/MNG-HA (Vice Chairman)
Dr. Majed Al Jeraisay
Dr. Majed Al JeraisayKAIMRC/MNG-HA (Member)
Dr. Ahmed AlGhamdi
Dr. Ahmed AlGhamdiSaudi Food and Drug Authority (Member)
Dr. Riyad Al Lehebi
Dr. Riyad Al LehebiKing Fahad Medical City (Member)
Prof. Ahmed Al Jedai
Prof. Ahmed Al Jedai Saudi Ministry of Health (Member)
Dr. Riad El Fakih
Dr. Riad El Fakih King Faisal Specialist Hospital and Research Center (Member)
Dr. Mahmoud Mosli
Dr. Mahmoud Mosli King Abdulaziz University Hospital (Member)
Dr. Fatima Cassim
Dr. Fatima Cassim AstraZeneca (Member)
Dr. Hani Al-Hashmi
Dr. Hani Al-HashmiPfizer (Member)
Prof. Tariq Alhawassi
Prof. Tariq AlhawassiKing Saud University (Member)
Dr. Paolo Martini
Dr. Paolo MartiniModerna (Member)
Dr. Mohamed Abdulkader
Dr. Mohamed AbdulkaderSanofi (Member)
Dr. Nasser Al Qahtani
Dr. Nasser Al QahtaniROCHE (Member)
Dr. Mohammed Alkelya
Dr. Mohammed AlkelyaSaudi Health Council (Member)
Dr. Rania Ashraf
Dr. Rania Ashraf J&J (Member)